[HTML] from thelancet.comL Gianni, U Dafni, RD Gelber, E Azambuja… - The Lancet …, 2011 - Elsevier The HERA trial is an international, multicentre, randomised, open-label, phase 3 trial comparing treatment with trastuzumab for 1 and 2 years with observation after standard neoadjuvant, adjuvant chemotherapy, or both in patients with HER2-positive early breast cancer. The primary ... Cited by 7 - Related articles - All 7 versions
[HTML] from oxfordjournals.orgFA Sinicrope, NR Foster… - Journal of the …, 2011 - jnci.oxfordjournals.org Methods We included stage II and III colon carcinoma patients (n = 2141) who were treated in randomized trials of 5-FU-based adjuvant therapy. Tumors were analyzed for microsatellite instability by polymerase chain reaction and/or for MMR protein expression by ... Cited by 1 - Related articles - All 5 versions
R Colombo, A Salonia, Z Leib… - BJU …, 2011 - Wiley Online Library Microwave-induced hyperthermia and mitomycin C is a device-assisted approach used to treat non-muscle invasive bladder cancer (NMIBC) either in the adjuvant (prophylactic) set-up or in an ablative regimen. Until recently, around 20 different studies have been published with ... Cited by 5 - Related articles - All 9 versions
RA Abrams, KA Winter, WF Regine… - International Journal of …, 2011 - Elsevier RT was scored for 416 patients: 216 PP and 200 <PP. For all pancreatic sites (head, body/tail) median survival (MS) for PP vs. <PP was 1.74 vs. 1.46 years (log–rank p = 0.0077). In multivariate analysis, PP vs. <PP score correlated more strongly with MS than ... Cited by 1 - Related articles - All 3 versions
[HTML] from ascopubs.orgGK Ellis, WE Barlow, JR Gralow… - Journal of Clinical …, 2011 - jco.ascopubs.org ... cooperative groups, specifically the North Central Cancer Treatment Group (NCCTG), Cancer and Leukemia Group B (CALGB), Eastern Cooperative Oncology Group (ECOG), National Surgical Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group ... Related articles - All 7 versions